metformin has been researched along with mangiferin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chellan, N; Joubert, E; Louw, J; Muller, CJ; Roux, C; Strijdom, H | 1 |
Malarvizhi, R; Mani, S; Nithya, P; Sekar, V; Vasanthi, HR | 1 |
Barathidasan, R; Malarvizhi, R; Mani, S; Sekar, V; Vasanthi, HR | 1 |
3 other study(ies) available for metformin and mangiferin
Article | Year |
---|---|
Aqueous extract of unfermented honeybush (Cyclopia maculata) attenuates STZ-induced diabetes and β-cell cytotoxicity.
Topics: Animals; Antioxidants; Blood Glucose; Cell Survival; Cyclopia Plant; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Metformin; Nitrites; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Streptozocin; Xanthones | 2014 |
Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Enzymes; Gene Expression Regulation; Gliclazide; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Metformin; Rats, Sprague-Dawley; Xanthones | 2019 |
Positive interaction of mangiferin with selected oral hypoglycemic drugs: a therapeutic strategy to alleviate diabetic nephropathy in experimental rats.
Topics: Animals; Antioxidants; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Gliclazide; Hypoglycemic Agents; Kidney; Kidney Function Tests; Male; Metformin; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Xanthones | 2020 |